Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 8/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9664232 | 0.93 | NOD1 (0.49) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL24095932 | 0.90 | KMT2A (0.58) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL7752876 | 0.86 | NOD1 (0.55) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL7756180 | 0.86 | NOD1 (0.55) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL3062723 | 0.86 | FAAH (0.56) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL21732833 | 0.86 | FAAH (0.56) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL9664089 | 0.86 | FAAH (0.56) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL23404043 | 0.86 | FAAH (0.56) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL9664208 | 0.86 | FAAH (0.56) | KMT2AMEN1FAAHMAPK1NOD1 | |
| SCHEMBL9664172 | 0.86 | FAAH (0.56) | KMT2AMEN1FAAHMAPK1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1547998-B1 | NOVEL COMPOSITION CONTAINING ACYL GROUP | ASAHI KASEI CHEMICALS CORP (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-20090093388-A1 | NOVEL ACYL GROUP-CONTAINING COMPOSITION | ASAHI KASEI CHEMICALS CORPORATION | 2009-04-09 | — | — | US | disclosed |
| US-7488841-B2 | Composition containing acyl group | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20050265951-A1 | Novel composition containing acyl group | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-1547998-A1 | NOVEL COMPOSITION CONTAINING ACYL GROUP | Asahi Kasei Chemicals Corporation (JP) | 2005-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093388-A1 | NOVEL ACYL GROUP-CONTAINING COMPOSITION | AADAC, ACADM, NAAA | KMT2A 1132/4885MEN1 4083/4885FAAH 230/4885 |
| US-20050265951-A1 | Novel composition containing acyl group | AADAC, ACADM, ADCK5 | KMT2A 1392/4885MEN1 3922/4885FAAH 258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.